ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #1,831Hybrid

Molecular Cancer Research

Abbreviation (ISO):MOL CANCER RES
•
Identifier (ISSN):1541-7786(Print)/1557-3125(Online)
•
Publisher:American Association for Cancer Research Inc.
Clarivate IF (2026)
5.8↑ +1.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Molecular Cancer Research

WoS Q2
24794.620184.4820194.6320205.8520216.3320225.220234.120244.720255.82026
Annual Impact Factor Metric
Current (2026):5.8
Scopus SJR & RankScopus Q1
1.759
#1,831

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
162

162 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate2.4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
174articles/year
25.19% Gold OA•92.81% Original Research

Aims & Scope

Molecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field. Studies must be of demonstrated significance, and the journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to cancer risk, development, and/or progression. Areas of emphasis include all cancer-associated pathways (including cell-cycle regulation; cell death; chromatin regulation; DNA damage and repair; gene and RNA regulation; genomics; oncogenes and tumor suppressors; signal transduction; and tumor microenvironment), in addition to studies describing new molecular mechanisms and interactions that support cancer phenotypes. For full consideration, primary research submissions must provide significant novel insight into existing pathway functions or address new hypotheses associated with cancer-relevant biologic questions.

Topics Covered (Recognized by AI)
Biology96.1%Genetics94.9%Medicine94.4%Chemistry91.6%Biochemistry91.4%Cancer research89.2%Internal medicine86%Gene77.4%Cancer75%Cell biology58.2%Apoptosis43.5%Signal transduction32.4%Cell culture28.6%Cell26.9%Immunology26%Pathology24.3%Phosphorylation23.1%Cancer cell20.7%Receptor20.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CELL BIOLOGY

Q2
Rank64/207
IndexSCIE
JCRSCIE2026

ONCOLOGY

Q1
Rank67/333
IndexSCIE
JCISCIE2026

CELL BIOLOGY

Q2
Rank76/207
IndexSCIE
JCISCIE2026

ONCOLOGY

Q2
Rank114/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF5.8
Articles / Year72
Total Citations15
2025
IF4.7
Articles / Year85
Total Citations227
2024
IF4.1
Articles / Year99
Total Citations558
2023
IF5.2
Articles / Year214
Total Citations2,029
2022
IF6.333
Articles / Year147
Total Citations2,345

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,831Scopus Q1SCImago Profile
Scopus Coverage:2002-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
1.759

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
5.65

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,683 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,740
3-Year Documents338
Citable Documents334

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate40.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1
Molecular BiologyQ1
OncologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Molecular Cancer Research (abbr: MOL CANCER RES, ISSN: 1541-7786) is a peer-reviewed international scholarly journal in the field of Medicine, published by American Association for Cancer Research Inc. in United States since 2002. The periodical holds a Journal Impact Factor (JIF) of 5.80, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.759 (Q1), an H-index of 162.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 174 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,683 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
American Association for Cancer Research Inc.
Publication Language
English
Frequency
Monthly
Founding Year
2002
Indexing & Databases
SCIEScopusPubMed
Editorial Address
AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: e79374d6-a4c4-441f-8790-29adaa8d231e
Database Updated: 2026-10-01